tiprankstipranks
Trending News
More News >
China Feihe Limited (HK:6186)
:6186
Hong Kong Market
Advertisement

China Feihe Limited (6186) AI Stock Analysis

Compare
13 Followers

Top Page

HK:6186

China Feihe Limited

(6186)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 4o)
Rating:55Neutral
Price Target:
HK$5.00
▲(21.07% Upside)
The overall score of 55 reflects strong financial health, tempered by significant technical weaknesses and modest valuation. The stock's technical analysis indicates bearish momentum, with the price below major moving averages and an oversold RSI. Despite a solid equity base and positive cash flow, declining net profit margins and inconsistent revenue growth raise concerns about future performance.
Positive Factors
Strong Brand Presence
China Feihe's strong brand presence and reputation for quality products support its competitive advantage in the infant milk formula market, promoting customer loyalty and sustaining long-term revenue.
Solid Financial Stability
A solid equity base and low debt-to-equity ratio provide China Feihe with financial stability, enabling it to withstand economic fluctuations and invest in growth opportunities.
Positive Cash Flow Generation
Stable operating cash flow ensures China Feihe can meet its financial obligations and invest in strategic initiatives, supporting long-term business sustainability.
Negative Factors
Declining Net Profit Margins
The decline in net profit margins suggests pressure on profitability, possibly due to increased costs or reduced pricing power, which could impact future earnings.
Inconsistent Revenue Growth
Inconsistent revenue growth raises concerns about China Feihe's ability to expand its market share and maintain steady income, potentially affecting long-term financial performance.
Decreased Return on Equity
A declining return on equity indicates challenges in generating returns for shareholders, which could impact investor confidence and the company's ability to attract capital.

China Feihe Limited (6186) vs. iShares MSCI Hong Kong ETF (EWH)

China Feihe Limited Business Overview & Revenue Model

Company DescriptionChina Feihe Limited, an investment holding company, produces and sells infant milk formula products in Mainland China and the United States. The company offers a range of raw milk, adult milk powders, liquid milk products and health care products, as well as soybean powder and goat milk powder. It is also involved in the retail of vitamins, minerals, herbs, and other nutritional supplements. The company sells its products through distributors; and e-commerce platforms, such as Tmall, JD.com, and Suning.com, as well as through its website and mobile application, including WeChat. As of December 31, 2021, it operated a distribution network of approximately 2,000 offline customers with 110,000 retail points of sale. China Feihe Limited was founded in 1962 and is headquartered in Beijing, the People's Republic of China.
How the Company Makes MoneyChina Feihe Limited generates revenue primarily through the sale of its infant formula products, which are marketed under several well-known brands. The company operates a multi-channel distribution strategy that includes online platforms, retail outlets, and direct sales to consumers, allowing it to reach a broad audience. Key revenue streams include domestic sales in China, where demand for high-quality infant formula continues to grow, and international sales as the company expands its market presence. Significant partnerships with retailers and e-commerce platforms enhance its distribution capabilities and visibility. Additionally, the company's investment in brand building and marketing efforts contributes to customer loyalty and repeat purchases, further bolstering its earnings.

China Feihe Limited Financial Statement Overview

Summary
China Feihe Limited demonstrates robust financial health with strong gross margins and a stable equity base. However, challenges with declining net profit margins, inconsistent revenue growth, and reduced return on equity indicate areas for improvement. Cash flow generation remains positive, ensuring the company can meet its financial obligations while supporting growth opportunities.
Income Statement
65
Positive
China Feihe Limited shows strong gross profit margins, consistently above 60% over the years, indicating efficient production and cost management. However, net profit margins have declined from 32.2% in 2020 to 17.2% in 2024, suggesting pressure on net income possibly due to increased costs or reduced pricing power. Revenue growth has been inconsistent, with a decline in recent years, impacting overall income performance.
Balance Sheet
72
Positive
The company maintains a solid equity base with an equity ratio consistently over 70%, indicating strong financial stability. The debt-to-equity ratio is low, demonstrating prudent debt management. However, the return on equity has decreased from 41.9% in 2020 to 13.8% in 2024, reflecting challenges in generating returns for shareholders despite a strong equity position.
Cash Flow
70
Positive
Operating cash flow has been stable, supporting the company's operational needs. Free cash flow remains positive, albeit experiencing some decline over the years. The free cash flow to net income ratio indicates efficient cash generation relative to net income, although the free cash flow growth rate has shown a negative trajectory, which may impact future cash reserves.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue19.80B20.75B19.53B21.31B22.78B18.59B
Gross Profit12.55B13.76B12.66B13.95B16.01B13.48B
EBITDA4.50B6.24B5.51B6.25B8.41B7.13B
Net Income2.70B3.57B3.39B4.94B6.87B7.44B
Balance Sheet
Total Assets33.90B35.73B36.19B35.52B31.48B28.32B
Cash, Cash Equivalents and Short-Term Investments16.86B19.00B19.15B19.11B17.18B16.41B
Total Debt845.01M1.08B1.64B1.50B1.11B1.42B
Total Liabilities6.75B8.32B9.86B10.04B9.08B9.14B
Stockholders Equity25.61B25.93B24.94B23.99B20.92B17.75B
Cash Flow
Free Cash Flow1.28B2.68B2.61B3.80B4.80B6.89B
Operating Cash Flow2.69B4.18B4.15B6.28B6.81B7.75B
Investing Cash Flow-1.04B-1.32B386.70M-4.80B-2.44B-3.79B
Financing Cash Flow-3.22B-3.03B-2.71B-1.98B-4.25B-2.54B

China Feihe Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.13
Price Trends
50DMA
4.10
Positive
100DMA
4.26
Negative
200DMA
4.93
Negative
Market Momentum
MACD
<0.01
Positive
RSI
45.49
Neutral
STOCH
10.56
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6186, the sentiment is Negative. The current price of 4.13 is below the 20-day moving average (MA) of 4.27, above the 50-day MA of 4.10, and below the 200-day MA of 4.93, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 45.49 is Neutral, neither overbought nor oversold. The STOCH value of 10.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6186.

China Feihe Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$106.36B8.4515.40%7.28%5.98%62.13%
67
Neutral
$60.08B12.8424.70%3.40%2.03%1.43%
67
Neutral
$64.09B14.4132.58%5.61%-1.68%22.06%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
HK$3.75B12.854.53%2.70%0.52%99.51%
56
Neutral
$57.15B-0.74%3.83%-7.36%-107.25%
55
Neutral
HK$38.13B13.1010.48%6.88%-0.64%-24.62%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6186
China Feihe Limited
4.15
-1.27
-23.43%
HK:0151
Want Want China Holdings
4.68
0.42
9.99%
HK:0288
WH Group
8.17
2.87
54.03%
HK:2319
China Mengniu Dairy Co
14.98
-1.46
-8.89%
HK:0322
Tingyi (Cayman Islands) Holding
11.97
2.76
29.98%
HK:1717
Ausnutria Dairy Corp. Ltd.
2.22
0.24
12.12%

China Feihe Limited Corporate Events

China Feihe Expands Agricultural Procurement with NL47 Agreement
Nov 5, 2025

China Feihe Limited has announced additional details regarding its NL47 Procurement Framework Agreement, which outlines the procurement of agricultural products at market prices determined through independent supplier quotes or mutual agreement. The company has set substantial annual caps for these transactions, reflecting an anticipated increase in demand driven by a growing membership on its e-commerce platform and various promotional activities. This strategic move is expected to significantly boost the company’s market presence and operational scale in the coming years.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Limited Invests RMB500 Million in SPD Bank Financial Products
Nov 5, 2025

China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to financial products offered by SPD Bank, amounting to RMB500 million. This move is part of the company’s strategy to utilize idle funds effectively, aiming to enhance capital gains while ensuring capital safety and liquidity. The subscription is expected to yield higher returns compared to traditional savings or time deposits, with minimal risk involved. The company assures that the investment will not impact its working capital or operations, maintaining the interests of the company and its shareholders.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Limited Enhances Capital Gains with Strategic Financial Product Subscription
Oct 27, 2025

China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to financial products from SPD Bank using RMB200 million of idle funds. This strategic move aims to enhance capital gains by utilizing surplus cash for treasury management, ensuring capital safety and liquidity, and supporting the company’s operational and dividend needs. The investment is expected to yield a higher return than typical savings or time deposits, with low associated risk, and is deemed fair and reasonable for the company and its shareholders.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Enters Procurement Agreement with North Latitude 47
Oct 14, 2025

China Feihe Limited has entered into a procurement framework agreement with North Latitude 47, effective from October 14, 2025, to December 31, 2027. This agreement allows Feihe HLJ, a subsidiary of China Feihe, to procure agricultural products from North Latitude 47. The transaction is classified as a continuing connected transaction under the Hong Kong Stock Exchange Listing Rules, requiring reporting and annual review but exempt from shareholder approval. This agreement is expected to enhance Feihe’s supply chain operations by securing essential agricultural products at market-competitive prices.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Limited Subscribes to CITIC Bank’s Wealth Management Products
Sep 24, 2025

China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to wealth management financial products offered by CITIC Bank, amounting to RMB400 million. This strategic move aims to utilize the company’s idle funds to enhance capital gains while maintaining low risk, aligning with the company’s core objectives of ensuring capital safety and liquidity. The subscription is expected to generate higher returns compared to typical savings or time deposits offered by commercial banks in the PRC. The company has implemented adequate internal controls to ensure this investment does not affect its working capital or operations, thereby protecting the interests of the company and its shareholders.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Limited Enhances Capital Gains Through Strategic Investment
Sep 17, 2025

China Feihe Limited has announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to a financial product offered by SPD Bank, investing RMB200 million using idle funds. This strategic move aims to enhance capital gains while maintaining low risk, aligning with the company’s objectives of ensuring capital safety and liquidity. The subscription is expected to provide a higher return compared to traditional savings, without impacting the company’s working capital or operations, thus benefiting shareholders.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Limited Enhances Capital Gains with Strategic Investment in SPD Bank Products
Sep 10, 2025

China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to financial products worth RMB300 million from SPD Bank using idle funds. This strategic move aims to enhance capital gains while maintaining low risk, aligning with the company’s objectives of ensuring capital safety and liquidity. The investment is expected to yield higher returns compared to traditional savings or time deposits, and the company has implemented internal controls to ensure that this investment does not affect its working capital or operations.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.30 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Limited Reports Decline in Interim Financial Results for 2025
Aug 28, 2025

China Feihe Limited reported its interim financial results for the first half of 2025, revealing a 9.4% decline in revenue to RMB9,150.5 million compared to the same period last year. The company’s gross profit decreased by 17.8%, and profit for the period fell by 46.0% to RMB1,032.5 million. These results indicate a challenging period for Feihe, potentially impacting its market positioning and stakeholder confidence.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$5.00 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Limited Declares Interim Dividend for 2025
Aug 28, 2025

China Feihe Limited has announced an interim cash dividend of HKD 0.1209 per share for the six months ending June 30, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may positively impact investor sentiment, reinforcing its stable financial position within the competitive dairy industry.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$5.00 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

China Feihe Limited Schedules Board Meeting for Interim Results
Aug 18, 2025

China Feihe Limited has announced that its board of directors will convene on August 28, 2025, to review and approve the company’s interim financial results for the first half of the year, ending June 30, 2025. The meeting will also consider the declaration of an interim dividend, highlighting the company’s ongoing commitment to shareholder returns and providing insights into its financial health and operational performance.

The most recent analyst rating on (HK:6186) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 08, 2025